Pfizer Revs Acquisition Engine; New Management Has $17 Bil. To Spend On Deals

Pfizer signs licensing agreement with Quark Biotech to develop a novel human gene for treatment of wet age-related macular degeneration.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet